In conclusion, treatment of 18β-GA on OVA-induced allergic airway inflammation can suppress eosinophilia, reduce the IgE level, pro-inflammatory cytokines level, and alleviate airway hyperresponsiveness, as evidenced by alleviation in respiratory tract inflammation and less mucus production. This evidence concerns the gene IGHE and Increased total eosinophil count.